Novavax Updates Financial Terms With Takeda for Covid-19 Vaccine Agreement in Japan
B. Riley Cuts Price Target on Novavax to $18 From $22, Keeps Buy Rating
Express News | Novavax Inc - Updated Agreement Includes Upfront Payment and Annual Milestones Related to Regulatory Approvals & Royalties on Net Sales Earned
Express News | Novavax Inc - Nuvaxovid to Remain Available in Japan
Express News | Novavax Announces Significantly Improved Terms for Collaboration and License Agreement With Takeda for Nuvaxovid® in Japan
Novavax Announces Significantly Improved Terms for Collaboration and License Agreement With Takeda for Nuvaxovid in Japan
Earnings Week Ahead: AMD, PLTR, F, DIS, SHOP, DKNG, AMC, LCID, GOLD, RIVN, and More
Earnings Preview: Novavax to Report Financial Results Pre-market on May 08
Novavax (NVAX) Flat As Market Gains: What You Should Know
Novavax Put Volume Heavy and Directionally Bearish
FDA to Tighten Vaccine Approval Requirements: Reports
Trump Administration Said to Be Investing $500M on Developing Universal Vaccines
Novavax to Report First Quarter 2025 Financial Results on May 8, 2025
Press Release: Novavax Appoints Charles Newton to Board of Directors
Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline
Novavax Appoints Charles Newton to Board of Directors
Novavax Says Company Is Aligned With Activist Investor on Measures Including Major Cost Cuts
Novavax Board 'Appreciates Support of Shah Capital'
Nvidia & Chip Stocks Falling, Novavax Vaccine, Zscaler Upgrade
Novavax Stock Is Up Again on Speculation Over the Fate of Its Covid Shot -- Barrons.com